Antheia
BiotechnologyWebsite
Antheia valuation and funding history | Last updated: June 3, 2025 | 2 funding rounds
Current Valuation
N/A
As of June 3, 2025
Total Funding Raised
$152.2M
Across 2 rounds
Last Round
Later Stage VC
$56.0M
Last Funding
Jun 2025
Funding date
Capital Efficiency
N/A
Valuation / Funding
Funding History & Valuation Timeline
Complete history of all funding rounds and valuation milestones
| Date | Round | Amount | Post-Valuation | Growth |
|---|---|---|---|---|
| January 27, 2026 | Later Stage VC (Series C) | $80.0M | N/A | - |
| June 30, 2021 | Later Stage VC (Series B) | $73.0M | N/A | - |
Valuation Analysis
Current Valuation Metrics
Antheia is currently valued at N/A as of June 3, 2025. The company has raised a total of $152.2M in funding across 2 funding rounds.
What is Antheia Worth in 2026?
Antheia is a leading private company in the Biotechnology sector. Track Antheia's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.
How Antheia Valuation is Determined
Private company valuations like Antheia's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.